Swiss-based venture capital firm redalpine has completed the final close of its eighth early-stage investment vehicle, redalpine capital VIII (RAC VIII), which gathered $250 million and exceeded its target. The fund counts institutional backers including Aviva Investors and KfW, alongside entrepreneurs and domain experts. Over the next period, RAC VIII will lead funding rounds in approximately 20 European companies working at the intersection of software and science.
RAC VIII represents the latest addition to redalpine's multi-stage platform, which now oversees more than $1.4 billion in total assets. The firm's approach allows it to support European founders from their earliest stages through to public markets.
Two decades backing frontier technology
Since its founding in Zurich in 2006, redalpine has maintained a focus on emerging technology domains including fusion energy, artificial intelligence, robotics, and biotechnology. A distinguishing feature of the firm is its investment team composition: roughly half hold scientific training in fields such as biology, physics, and engineering, enabling rigorous assessment of complex technical ventures from their inception.
Twenty years ago, we started redalpine with the conviction that the most important companies would emerge where software and science meet. That belief hasn't changed. With RAC VIII, we're excited to keep backing these founders early, before the opportunity is obvious.
Dr. Michael Sidler, Founding Partner at redalpine
AI is leveling the playing field more than ever. The advantage now lies with whoever understands the underlying science and the hardest problems best, and that has always been Europe's strength. We're seeing a new generation of highly ambitious founders who are determined to build and scale world-leading tech companies from here and establish Europe as a global technology power.
Sebastian Becker, General Partner at redalpine
Portfolio track record and recent exits
redalpine's portfolio encompasses companies such as Proxima Fusion, Mistral AI, N26, Basecamp Research, and microagi, alongside more than 100 additional investments. The firm has achieved 12 portfolio exits since 2023, a notable accomplishment during a period marked by limited exit activity across the technology sector.
RAC VII, the predecessor fund that closed in 2024, has seen its backed companies raise over $1.1 billion in subsequent funding rounds.
redalpine was early in understanding Proxima's potential for Europe's energy future and led our Seed round. With RAC VIII, they can bring that same speed and technical depth to more founders tackling genuinely hard and important problems.
Francesco Sciortino, Co-Founder & CEO of Proxima Fusion
First RAC VIII investments announced
The fund has already deployed capital into three initial companies: Enact Intelligence, which develops force intelligence systems for robotics; Helical, creating a virtual AI laboratory for drug discovery reproducibility; and Arlequin AI, working on novel AI architectures for critical infrastructure protection.
In total, RAC VIII will select around 20 portfolio companies from a pool of over 5,000 applicants annually. The fund will predominantly lead Seed and Series A financing rounds, with initial cheques typically ranging from $1 million to $15 million.
Institutional backing and European commitment
RAC VIII drew both returning and new limited partners to the vehicle, including Aviva Investors, Flexstone Partners, and KfW. This investor composition signals growing institutional commitment from European sources toward deeptech and frontier technology ventures. Beyond institutional capital, the fund also attracted backing from seasoned entrepreneurs, executives with specialized domain knowledge, and business owners who provide operational guidance to redalpine's portfolio.
redalpine has a proven track record in backing fantastic European businesses that are at the forefront of technology and scientific innovation. At a time when global VC markets are competing more intensely than ever for investor capital, we are thrilled to partner with the team at redalpine and believe it can help us gain greater access to support some of the most exciting, high-growth, disruptive and innovative start-ups across the UK and Europe. We view partnerships like this as being vital for the continued growth of our portfolio and, ultimately, supporting the delivery of long-term investment outcomes for pension investors.
Cynthia Chen, Head of Fintech at Aviva Investors
Building a multi-stage platform
redalpine's evolution from a single early-stage fund into a comprehensive multi-stage platform reflects its ambition to support founders at every phase of company development. This structural approach also serves redalpine's broader mission: strengthening Europe's venture capital infrastructure and ensuring that value generated by European technology enterprises flows back to local investors, including pension funds.
European self-confidence is back, and nowhere more visibly than among institutional investors, who are now putting real conviction behind European technology. Our fund platform lets us back founders from Seed to scale, so we can keep supporting them as they grow into global category leaders.
Rafael Hubatschek, Partner and Head of Investor Relations at redalpine
About redalpine
redalpine operates as a pan-European venture capital firm focused on software and science companies spanning Seed through IPO stages. Established in Zurich in 2006, the firm maintains offices in Zug, Berlin, and London, with additional presence in Silicon Valley. The organisation combines financial capital, operational support, and international networks to help founders realise their ambitions. With $1.4 billion in assets under management and a portfolio exceeding 100 companies, redalpine has backed transformative European ventures including Proxima Fusion, Mistral, N26, Basecamp Research, and Microagi.
Source: The Next Web
